Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Cancer Prev Res (Phila). 2011 May;4(5):638-54. doi: 10.1158/1940-6207.CAPR-10-0326.

    Mitochondrial subversion in cancer.

    Source

    Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, MD, USA.

    Abstract

    Mitochondria control essential cellular activities including generation of ATP via oxidative phosphorylation. Mitochondrial DNA (mtDNA) mutations in the regulatory D-loop region and somatic mtDNA mutations are common in primary human cancers. The biological impact of a given mutation may vary, depending on the nature of the mutation and the proportion of mutant mtDNAs carried by the cell. Identification of mtDNA mutations in precancerous lesions supports their early contribution to cell transformation and cancer progression. Introduction of mtDNA mutations in transformed cells has been associated with increased ROS production and tumor growth. Studies reveal that increased and altered mtDNA plays a role in the development of cancer but further work is required to establish the functional significance of specific mitochondrial mutations in cancer and disease progression. This review offers some insight into the extent of mtDNA mutations, their functional consequences in tumorigenesis, mitochondrial therapeutics, and future clinical application.

    PMID:
    21543342
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3298745
    Free PMC Article

    Images from this publication.See all images (5)Free text

    Figure 1
    Figure 2
    Figure 3
    Figure 4
    Figure 5

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk